Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2.
about
Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies"Selective Inhibition of Human Group IIA-secreted Phospholipase A2 (hGIIA) Signaling Reveals Arachidonic Acid Metabolism Is Associated with Colocalization of hGIIA to Vimentin in Rheumatoid SynoviocytesThe roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infectionsEndothelial targeting of cowpea mosaic virus (CPMV) via surface vimentinCharacterization of a human coagulation factor Xa-binding site on Viperidae snake venom phospholipases A2 by affinity binding studies and molecular bioinformatics.Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivoVimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome.Vimentin mediates uptake of C3 exoenzyme."New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndromeDetection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessmentAutoantibodies to vimentin cause accelerated rejection of cardiac allografts.Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIAArthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice.Role of anti-vimentin antibodies in allograft rejection.Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry.Superficial vimentin mediates DENV-2 infection of vascular endothelial cells.Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.sPLA2-IIa is an inflammatory mediator when the ocular surface is compromisedIntracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.Matrix metalloproteinase processing of signaling molecules to regulate inflammation.Downregulation of vimentin in macrophages infected with live Mycobacterium tuberculosis is mediated by Reactive Oxygen Species.Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family.Precise epitope determination of the anti-vimentin monoclonal antibody V9.The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes.Involvement of IbeA in meningitic Escherichia coli K1-induced polymorphonuclear leukocyte transmigration across brain endothelial cells.Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif.Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates.
P2860
Q26780481-5F756E22-10A7-42D0-B471-5937EAE7DA29Q27676774-66B81B9B-802A-438B-B3DC-67854680B18FQ28388621-9E024154-1D53-4A93-A874-EE92D7B6BD8DQ28475414-B925FAAE-102E-4CA4-ADCD-2F5C3B0548D4Q33308925-69E14B88-5AF1-4D42-8452-57F4AE8174B9Q33517131-BA6A21EB-792F-4A20-87DE-15020665ECF2Q33707996-FE87B7EA-0F92-4A6E-B880-05149E48192EQ34684028-F0F46325-0CE3-4A64-9CCC-7099C6977F2FQ35195338-1E3AC507-D22B-4F52-924D-07EDB1F7E27BQ35250419-68917D1C-9CF7-4645-AE78-D0D48159BB68Q35542696-D089C006-D589-45B2-8D81-2980BCB8723BQ35691658-8F06F085-C185-4B44-95A9-11EA808085E0Q35845952-3521FE5E-4637-46A6-8A26-EB702313B5C1Q36537972-CB5AC5D8-747A-4B8D-9D29-258CBA25B807Q37286553-5A7981C8-79B8-44A6-BA12-D21371E22671Q37416014-520B9CC2-DDC7-4577-9606-78A189591A09Q37464522-5EBFFFDC-AB91-4610-8005-16BFEC7595FAQ37682418-576532DB-36B1-4FA4-868C-D1006B2E1FE3Q37726033-6BBD2F60-11C7-48DE-AF29-F9FA339E59B2Q37784801-026B71DE-8FC9-4634-B2F5-F9C2A81879A1Q38127780-2F683029-0537-405D-8FBC-A68C5DCE965EQ38432005-2765D4D8-6A78-4A35-B976-2D2E7D02ED81Q40331155-0271894E-537A-41E8-946D-F5CD8FBE1952Q42679534-19654FAA-FFC9-49D0-963D-C503FE08AB29Q43240413-4F261E98-991A-4373-A504-4BF6759BF2D6Q46072398-D8C5021E-1EC2-40A6-8F2F-9259FBDBDCBDQ46920946-834548F0-E8C0-414E-830D-96136A688107Q47105912-DB2D8C6E-A68B-4C69-95AC-227D16867286Q53657340-E0E61B26-758B-4F0A-8ABC-3D708CAB8435
P2860
Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Identification of an autoantig ...... ry group IIA phospholipase A2.
@ast
Identification of an autoantig ...... ry group IIA phospholipase A2.
@en
type
label
Identification of an autoantig ...... ry group IIA phospholipase A2.
@ast
Identification of an autoantig ...... ry group IIA phospholipase A2.
@en
prefLabel
Identification of an autoantig ...... ry group IIA phospholipase A2.
@ast
Identification of an autoantig ...... ry group IIA phospholipase A2.
@en
P2093
P1433
P1476
Identification of an autoantig ...... ry group IIA phospholipase A2.
@en
P2093
Chantale Bernatchez
Eric Boilard
Marc E Surette
Sylvain G Bourgoin
P304
P356
10.1182/BLOOD-2002-12-3702
P407
P577
2003-06-26T00:00:00Z